acarbose (Prandase) decreases the risk of hypertension and heart disease in PRE-diabetes patients
September 2003
New evidence suggests that acarbose (Prandase) decreases the risk of hypertension and heart disease in PRE-diabetes patients.
Many of these patients develop type 2 diabetes...and can have up to a 10 times higher risk of heart disease-related death.
Pre-diabetes patients who take acarbose over 3 years have a lower risk of developing diabetes...hypertension...and heart disease.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive